L’ex-toxicologue de PFIZER sort du silence (Dr. Helmut Sterz)

Main arguments and claims

• Toxicology standards were diluted and outsourced, reducing internal expertise in pharma companies over decades. Sterz describes this as a cost-cutting trend that made toxicology less robust and more dependent on subcontractors.
• During COVID, he argues toxicity testing was “mediocre/insufficient.” He claims Pfizer/BioNTech relied on limited studies—such as simplified general toxicity work in rats and restricted reproductive/general toxicity design. He attributes this partly to company and contractor choices, but also to non-pharmaceutical decision structures behind the campaign.
• “Technology” is framed as the core danger, not individual drugs. He claims the underlying mRNA platform carries risks because production changes led to more impurity (e.g., residual bacterial DNA from manufacturing), which he says could cause long-term adverse effects, including cancer and reproductive harm.
• He argues the COVID response lacked key studies, especially for:
  • longer-duration toxicity work,
  • mutagenesis, immunotoxicity, and reproductive studies in appropriate depth,
  • interaction studies with other vaccines or concurrent medications,
  • juvenile-animal studies,
  • and for specific risk groups including elderly, children/juveniles, and pregnancy/reproduction.
• He contends that urgency and governance structures replaced normal scientific safeguards. He claims contracts and liability frameworks limited responsibility for efficacy/safety science, focusing Pfizer mainly on manufacturing capacity.
• He claims official reporting and labeling affected observed harms. He alleges deaths after vaccination were frequently categorized as COVID deaths, obscuring vaccine safety signals.
• He asserts pharmacovigilance signals show broad multi-organ injury, pointing to rises in reports in 2021 and alleging real effects (including reproductive outcomes). He highlights abortion statistics as an example of a pattern he says is not driven by anti-vaxxer behavior.
• He argues vaccines function within a specific economic/legal model. Recurring vaccination schedules create predictable revenue, and emergency legislation/litigation shields reduce accountability—citing the U.S. PREP Act framework.
• He rejects a simplistic “Big Pharma wants to keep us sick” conspiracy, but argues pharma still promotes medication use because it benefits business and creates “comfort solutions,” contributing to overuse and normalization of treatments.

Critiques of COVID vaccine execution (his specific thesis)

• COVID was treated as an emergency, so “everything that took time” was allegedly dropped.
• He claims minimal general toxicity and minimized reproductive toxicology were used, with dose-selection that (in his framing) avoided uncovering problems (“cover-up” framing).
• He argues the campaign shifted from emergency vaccination to something closer to repeated, ongoing treatment (boosters), requiring—according to him—a different and more extensive testing strategy.

Outlook and broader warning

• He warns similar issues could repeat as “many products in the pipeline” adopt related biotech/mRNA-like technologies.
• He advises not a blanket anti-biotech stance, but greater scrutiny:
  • avoid vaccinating where disease risk is low for one’s region,
  • avoid unnecessary over-vaccination in children (he argues cumulative burden matters),
  • consider personal risk/benefits and skepticism toward mass mandates.

Personal/policy-related positions included in the video

• He argues public trust has been damaged by COVID politics and suppression of dissent, contributing to long-lasting reluctance toward vaccination.
• He expects limited accountability and doubts governments/commissions will truly investigate or punish responsible parties.

Disputed/controversial quantitative claims (presented in the video)

• He suggests very large global harm estimates (e.g., 20–30 million deaths) and large numbers for Germany (he cites ~60,000 vaccine deaths attributed in his testimony).
• He claims “more serious problems” occur in a meaningful share of recipients depending on batch, while also stating that most people have no symptoms.

Presenters / contributors (named in the subtitles)

• Dr. Helmut Sterz (toxicologist; main interviewee)
• Elmout Cert / (Elmout) Cert (interviewer / host)
• Christophe Cariot (mentioned in an ad segment about “Nutripur”)
• Professor Pon (mentioned)
• Dr. Louis Foucher (mentioned; referenced as another guest)
• Bill Gates (mentioned)
• George Soros (mentioned)
• WHO (mentioned)
• Mr. Gates (referred to; appears to be the same as Bill Gates)
• Fauci (mentioned)
• Donald Trump (mentioned)
• Kennedy (mentioned)
• Merkel (mentioned)
• Mr. Musk (mentioned; referenced as reacting via tweet)
• BioNTech (mentioned)
• Pfizer (mentioned)
• Bergamo (mentioned as a reference point)
• Contergan / thalidomide (mentioned as historical context)